| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |